My Patient Portal Login
Bill Pay
ILCC Foundation
Patient Resources
Careers
Pharmaceutical Representatives
Phone:
309.243.3000
or
1.866.662.6564
Pharmacy Phone:
309.243.3404
Home
Why ILCC
Locations
Mission / Values
History
Foundation
Testimonials
Our Staff
Patient Information
News
Smart Care
Laboratory
Pharmacy
Resources
Quality Assurance
Contact Us
Cancer Treatment
Treatment Overview
Your Visit
List of Cancer Types
What To Ask Your Doctor
Personalized Cancer Care
Pallative Care
Smart Care
Chemotherapy
Radiology
Other Treatments
Laboratory
Cancer FAQ
Blood Disorders
Treatment Overview
Your Visit
List of Blood Disorders
What To Ask Your Doctor
Smart Care
Laboratory
Blood Disorders FAQ
Genetics Clinic
Genetics Overview
Your Visit
Risk Assessment
Appointment Request
Future of Genetics
Genetics FAQ
Clinical Trials
What Are Clinical Trials
Current Trials
Research Overview
Research FAQ
Research Resources
Ask A Researcher
Molecular Testing
Financial Conflict of Interest
Contact
Send Us An Email
Our Locations
Careers
Forms
Submit Your Story
Recent News
FAQ
Search Results
Search Results for
AFT-25
Comparison of Operative to Monitoring and Endocrine Therapy (COMET) Trial For Low Risk DCIS
Continue Reading »
Search Again
All Trial Categories
Anal (3)
Bladder/Urinary Tract Cancer (8)
Adjuvant (1)
Metastatic (2)
Neoadjuvant (4)
Brain (7)
Glioblastoma Multiforme (GBM) (3)
Other Brain Tumors (3)
Breast (17)
1st Line Metastatic Breast, Metastasis at Presentation or Progression of earlier Disease (5)
2nd Line Metastatic Breast, Progressive Disease Following 1st Line Therapy (1)
Breast Cancer Adjuvant (5)
Breast Cancer Neoadjuvant (1)
DCIS/LCIS (1)
Cancer Control/Symptom Management (22)
Carcinoid Tumors (2)
Colorectal Cancer (9)
Metastatic (4)
Esophageal Cancer (2)
Gall Bladder/ Biliary Tract Cancer (1)
Gastric Cancer (2)
Metastaic Gastric Cancer (1)
Head/Neck Cancer (4)
Resectable Oral Cavity Cancer (1)
Primary Chemoradiation Regimens (1)
Leukemia (9)
Acute Myeloid Leukemia (AML) (1)
B-Cell Chromic Lymphocytic Leukemia (CLL) / Small Ly (5)
Liver/Hepatocellular Carcinoma (1)
Lung Cancer (24)
Non-Small Cell Lung Cancer (19)
1st Line Metastatic, Stage3b with Maligned Effusion or Stage 4 Disease at Presentation or Recurrence (3)
2nd Line Metastatic, Stage 4 Patients with Progressive Disease (4)
Adjuvant Treatment for Resected NSCLC (4)
Small Cell Lung Cancer (5)
Extensive Stage SCLC (2)
Lymphoma (9)
Non-Hodgkin’s Lymphoma (4)
Diffuse Large B-Cell Lymphoma (1)
Follicular Lymphoma (2)
Relapsed/Refractory (2)
MATCH Trial (1)
MDS (3)
Melanoma (7)
Metastatic (3)
Merkel Cell Carcinoma (1)
Multiple Myeloma (2)
Pancreatic (6)
Metastatic Disease (4)
Prostate (9)
Renal Cell/Kidney Cancer (6)
Locally Advanced/Metastatic (4)
Sarcoma (2)
Small Bowel (1)